EUVIMEDEUVIMED entdecken
Vergleichsstudie

Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals

Tomonobu Uchino, Michiaki Nakajo, Ichiro Hatta, Ikumi Suzuki, Mayuko Okada, Rikuto Terada, Yasunori Miyazaki, Misa Osawa, Keisei Taku, Tasuku Yokoyama, Daiki Tsuji, Yoshiyuki Kagawa

Cancer Chemotherapy and Pharmacology · 2026

DOI: 10.1007/s00280-025-04842-0 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2026. Verfasst von Tomonobu Uchino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, J…. Hauptthemen laut MEDLINE: Capecitabine, Hand-Foot Syndrome, Lipids. Die Arbeit nennt 36 Literaturangaben. Gefördert von: University of Shizuoka academic research grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Capecitabine (CAP) side effect, a prodrug of 5-fluorouracil (5-FU), is hand-foot syndrome (HFS), a localized skin disorder of the hands and feet that is believed to induce a decrease in skin barrier function. Stratum corneum (SC) lipids play an important role in skin barrier function; therefore, this study compared the SC lipid structure and composition of healthy participants with those of patients with CAP-induced HFS. METHODS: Forty patients receiving a combination regimen of CAP and oxaliplatin as adjuvant chemotherapy for colorectal cancer were enrolled. All patients received 1,000 mg/m2 twice daily on days 1-14. SC samples were obtained from 11 patients with CAP-induced HFS (CSC). The SC lipid structure was analyzed using synchrotron X-ray diffraction. SC lipid components, ceramides (CERs), free fatty acids (FFAs), CAP, and its metabolites in CSC samples were analyzed using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). RESULTS: In healthy SC (HSC), lipids formed two lamellar phases. Hexagonal and orthorhombic hydrocarbon chain packing was observed in lateral lipid organization. However, in CSC, these structures have almost disappeared. UPLC-MS/MS analysis revealed that the composition of CER and FFA differed between CSC and HSC, and that the carbon chain length of SC lipid components in CSCs was reduced compared to that in HSCs. 5-FU was detected in CSCs at 3.4 ± 1.4 ng/mg. CONCLUSION: CAP induces changes in SC lipid structure due to changes in SC lipid composition and a decrease in carbon chain length in CSCs. CAP-induced HFS is associated with 5-FU accumulation in SC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapecitabineHand-Foot SyndromeLipidsHumansMaleAgedMiddle AgedFemaleColorectal NeoplasmsTandem Mass SpectrometryAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsOxaliplatinAdult

Stichwörter der Autor:innen

CapecitabineCeramideHand-foot syndromeLamellar structureLateral structureStratum corneum

Substanzen

CapecitabineLipidsAntimetabolites, AntineoplasticOxaliplatin

Autor:innen und Institutionen

  • Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.
  • Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.
  • Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan. uchinot@u-shizuoka-ken.ac.jp.
  • Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
  • Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.
  • Department of Research, Nagoya Industrial Science Research Institute, 1-13 Yotsuyadori, Chikusa-ku, Nagoya, 464-0819, Japan.

Förderung

  • University of Shizuoka academic research grant

Zitieren

APA

Uchino, T., Nakajo, M., Hatta, I., Suzuki, I., Okada, M., Terada, R., Miyazaki, Y., Osawa, M., Taku, K., Yokoyama, T., Tsuji, D., & Kagawa, Y. (2026). Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-025-04842-0

Vancouver

Uchino T, Nakajo M, Hatta I, Suzuki I, Okada M, Terada R, et al. Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals. Cancer Chemotherapy and Pharmacology. 2026. doi:10.1007/s00280-025-04842-0

BibTeX
@article{Uchino2026,
  author = {Uchino, Tomonobu and Nakajo, Michiaki and Hatta, Ichiro and Suzuki, Ikumi and Okada, Mayuko and Terada, Rikuto and Miyazaki, Yasunori and Osawa, Misa and Taku, Keisei and Yokoyama, Tasuku and Tsuji, Daiki and Kagawa, Yoshiyuki},
  title = {Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2026},
  doi = {10.1007/s00280-025-04842-0}
}
Kostenlos starten →